원발성 알도스테론증으로 부신 절제술 받은 환자의 수술 후 결과에 대한 분석
Postoperative Outcomes in Patients Undergoing Adrenalectomy for Primary Aldosteronism
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Primary aldosteronism (PA) is characterized by hypertension (HTN), hypokalemia, suppressed plasma renin activity, and inappropriate aldosterone secretion. The purpose of this study was to analyze postoperative results on blood pressure (BP), and to determine the factors associated with resolution of HTN after adrenalectomy for PA. Methods: One hundred eight patients (66 females and 42 males) with a mean age of 46 years underwent adrenalectomy for PA between January 1, 1996 and September 30, 2009. Their clinical characteristics and biochemical parameters were reviewed retrospectively. Results: All patients had HTN preoperatively and 20 patients (18.1%) had uncontrolled HTN. Hypokalemia was evident in 89.1% of patients, cardiovascular events in 4.5% and cerebrovascular events in 8.2%. There was a significant decrease in both systolic BP and diastolic BP postoperatively, as compared with that before operation. Median systolic BP decreased from 150 mmHg to 125 mmHg at the last follow-up (P＜0.01), and median diastolic BP decreased from 93.5 mmHg to 81.5 mmHg (P＜0.01). Sixty two (57.4%) patients were cured of HTN and did not require any hypertensive agent, and 38 (35.1%) patients had an improvement in BP control, whereas 9 (8.3%) patients had no change in BP. Univariate analysis showed that duration of HTN and more than two HTN treatment agents were independent factors predicting sustained hypertension after surgery. Conclusion: The duration of HTN and the severity of HTN are factors influencing persistence of HTN after operation for a PA. (Korean J Endocrine Surg 2011;11:276-282)
Abstract
Purpose: Primary aldosteronism (PA) is characterized by hypertension (HTN), hypokalemia, suppressed plasma renin activity, and inappropriate aldosterone secretion. The purpose of this study was to analyze postoperative results on blood pressure (BP), and to determine the factors associated with resolution of HTN after adrenalectomy for PA. Methods: One hundred eight patients (66 females and 42 males) with a mean age of 46 years underwent adrenalectomy for PA between January 1, 1996 and September 30, 2009. Their clinical characteristics and biochemical parameters were reviewed retrospectively. Results: All patients had HTN preoperatively and 20 patients (18.1%) had uncontrolled HTN. Hypokalemia was evident in 89.1% of patients, cardiovascular events in 4.5% and cerebrovascular events in 8.2%. There was a significant decrease in both systolic BP and diastolic BP postoperatively, as compared with that before operation. Median systolic BP decreased from 150 mmHg to 125 mmHg at the last follow-up (P＜0.01), and median diastolic BP decreased from 93.5 mmHg to 81.5 mmHg (P＜0.01). Sixty two (57.4%) patients were cured of HTN and did not require any hypertensive agent, and 38 (35.1%) patients had an improvement in BP control, whereas 9 (8.3%) patients had no change in BP. Univariate analysis showed that duration of HTN and more than two HTN treatment agents were independent factors predicting sustained hypertension after surgery. Conclusion: The duration of HTN and the severity of HTN are factors influencing persistence of HTN after operation for a PA. (Korean J Endocrine Surg 2011;11:276-282)
참고문헌 (27)
- Conn JW, "Primary aldosteronism, a new clinical entity", Ann Intern Med, 44, pp.1~15 (1956)
- Giacchetti G, "Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol", J Hypertens, 24, pp.737~745 (2006)
- Plouin PF, "Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension", Nephrol Dial Transplant, 19, pp.774~777 (2004)
- Mulatero P, "Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents", J Clin Endocrinol Metab, 89, pp.1045~1050 (2004)
- Campagnacci R, "Long-term results of laparoscopic adrenalectomy for primary aldosteronism", J Endocrinol Invest, 32, pp.57~62 (2009)
- Fowler DL, "Laparoscopic adrenalectomy: there can be no doubt", Ann Surg Oncol, 10, pp.997~998 (2003)
- Gockel I, "Long-term results of endoscopic adrenalectomy for Conn's syndrome", Am Surg, 73, pp.174~180 (2007)
- Goh BK, "Outcome of patients undergoing laparoscopic adrenalectomy for primary hyperaldosteronism", JSLS, 8, pp.320~325 (2004)
- Gordon RD, "Mineralocorticoid hypertension", Lancet, 344, pp.240~243 (1994)
- Rizzoni D, "Vascular hypertrophy and remodeling in secondary hypertension", Hypertension, 28, pp.785~790 (1996)
- Strauch B, "Adrenalectomy improves arterial stiffness in primary aldosteronism", Am J Hypertens, 21, pp.1086~1092 (2008)
- Funder JW, "Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline", J Clin Endocrinol Metab, 93, pp.3266~3281 (2008)
- Nishizaka MK, "Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension", Am J Hypertens, 18, pp.805~812 (2005)
- Catena C, "Cardiovascular outcomes in patients with primary aldosteronism after treatment", Arch Intern Med, 168, pp.80~85 (2008)
- Milliez P, "Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism", J Am Coll Cardiol, 45, pp.1243~1248 (2005)
- Rocha R, "Pathophysiological effects of aldosterone in cardiovascular tissues", Trends Endocrinol Metab, 12, pp.308~314 (2001)
- Sechi LA, "Long-term renal outcomes in patients with primary aldosteronism", JAMA, 295, pp.2638~2645 (2006)
- Blumenfeld JD, "Diagnosis and treatment of primary hyperaldosteronism", Ann Intern Med, 121, pp.877~885 (1994)
- Obara T, "Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism", Surgery, 112, pp.987~993 (1992)
- Sawka AM, "Primary aldosteronism: factors associated with normalization of blood pressure after surgery", Ann Intern Med, 135, pp.258~261 (2001)
- Giacchetti G, "Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma", Eur J Endocrinol, 160, pp.639~646 (2009)
- Meyer A, "Long-term follow-up after adrenalectomy for primary aldosteronism", World J Surg, 29, pp.155~159 (2005)
- Fukudome Y, "Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy", Hypertens Res, 25, pp.11~18 (2002)
- TAIPAI Study Group, "Association of kidney function with residual hypertension after treatment of aldosterone -producing adenoma", Am J Kidney Dis, 54, pp.665~673 (2009)
- Young WF, "Role for adrenal venous sampling in primary aldosteronism", Surgery, 136, pp.1227~1235 (2004)
- Auchus RJ, "What we still do not know about adrenal vein sampling for primary aldosteronism", Horm Metab Res, 42, pp.411~415 (2010)
- Sukor N, "Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience", J Clin Endocrinol Metab, 94, pp.2437~2445 (2009)